MFDS
- Status: likely_approved
🇰🇷 Cantil in South Korea
Cantil (MEPENZOLATE) regulatory status in South Korea.
Marketing authorisation
Cantil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Gastroenterology approved in South Korea
Frequently asked questions
Is Cantil approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Cantil in South Korea?
Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.